Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074032261> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2074032261 endingPage "743" @default.
- W2074032261 startingPage "743" @default.
- W2074032261 abstract "Purpose: The purpose of this study was to investigate the prophylactic effect of brimonidine 0.15% on intraocular pressure (IOP) elevation and the risk factors for its elevation after intravitreal triamcinolone acetonide injection (IVTA). Methods: A prospective, randomized clinical trial was conducted on 67 eyes of 64 patients undergoing IVTA. Eyes were randomly divided into two groups, those which had used brimonidine 0.15% (40 eyes) and those which had not used it (27 eyes). IOP was measured preoperatively, at one week, and monthly until six months post-injection in each group. Results: The mean post‐injection IOP at one week was 11.93±3.36 mmHg for the group that had used brimonidine and 13.58±3.25 mmHg for the group that had not used it. The difference between the two groups was statistically significant at one week (p=0.049), but others were not statistically significant. An elevation in the IOP of more than 22 mmHg was seen in 8 eyes (20%) in the group using brimonidine and in 7 eyes (25.9%) in the group not using brimonidine. There was no difference in the incidence of IOP elevation between the two groups. Conclusions: Prophylactic use of brimonidine 0.15% will prevent sudden IOP elevation and will, therefore, prevent damage to the retina and optic nerve. However, in the long term, there is no prophylactic effect of brimonidine 0.15% on IOP elevation because there was no difference in the incidence of IOP elevation of more than 22 mmHg between the two groups." @default.
- W2074032261 created "2016-06-24" @default.
- W2074032261 creator A5022967070 @default.
- W2074032261 creator A5031415304 @default.
- W2074032261 creator A5086982168 @default.
- W2074032261 date "2008-01-01" @default.
- W2074032261 modified "2023-10-16" @default.
- W2074032261 title "Prophylactic Effect of Brimonidine 0.15% on IOP Elevation After Intravitreal Triamcinolone Acetonide Injection" @default.
- W2074032261 cites W1964444582 @default.
- W2074032261 cites W1964499056 @default.
- W2074032261 cites W1971299849 @default.
- W2074032261 cites W1977320457 @default.
- W2074032261 cites W1987678274 @default.
- W2074032261 cites W1997013893 @default.
- W2074032261 cites W2014695654 @default.
- W2074032261 cites W2033885795 @default.
- W2074032261 cites W2034261875 @default.
- W2074032261 cites W2039852137 @default.
- W2074032261 cites W2048196019 @default.
- W2074032261 cites W2076709879 @default.
- W2074032261 cites W2079324681 @default.
- W2074032261 cites W2085681324 @default.
- W2074032261 cites W2086996191 @default.
- W2074032261 cites W2089181107 @default.
- W2074032261 cites W2122468033 @default.
- W2074032261 cites W2134178766 @default.
- W2074032261 cites W2135333970 @default.
- W2074032261 cites W2136379937 @default.
- W2074032261 cites W2146755607 @default.
- W2074032261 cites W2149062776 @default.
- W2074032261 cites W2166215067 @default.
- W2074032261 cites W2170586585 @default.
- W2074032261 cites W2227559147 @default.
- W2074032261 cites W3202352366 @default.
- W2074032261 cites W4247363344 @default.
- W2074032261 doi "https://doi.org/10.3341/jkos.2008.49.5.743" @default.
- W2074032261 hasPublicationYear "2008" @default.
- W2074032261 type Work @default.
- W2074032261 sameAs 2074032261 @default.
- W2074032261 citedByCount "4" @default.
- W2074032261 countsByYear W20740322612014 @default.
- W2074032261 countsByYear W20740322612018 @default.
- W2074032261 crossrefType "journal-article" @default.
- W2074032261 hasAuthorship W2074032261A5022967070 @default.
- W2074032261 hasAuthorship W2074032261A5031415304 @default.
- W2074032261 hasAuthorship W2074032261A5086982168 @default.
- W2074032261 hasBestOaLocation W20740322611 @default.
- W2074032261 hasConcept C118487528 @default.
- W2074032261 hasConcept C2524010 @default.
- W2074032261 hasConcept C2776251621 @default.
- W2074032261 hasConcept C2778190193 @default.
- W2074032261 hasConcept C2778903070 @default.
- W2074032261 hasConcept C2781092963 @default.
- W2074032261 hasConcept C33923547 @default.
- W2074032261 hasConcept C37054046 @default.
- W2074032261 hasConcept C71924100 @default.
- W2074032261 hasConceptScore W2074032261C118487528 @default.
- W2074032261 hasConceptScore W2074032261C2524010 @default.
- W2074032261 hasConceptScore W2074032261C2776251621 @default.
- W2074032261 hasConceptScore W2074032261C2778190193 @default.
- W2074032261 hasConceptScore W2074032261C2778903070 @default.
- W2074032261 hasConceptScore W2074032261C2781092963 @default.
- W2074032261 hasConceptScore W2074032261C33923547 @default.
- W2074032261 hasConceptScore W2074032261C37054046 @default.
- W2074032261 hasConceptScore W2074032261C71924100 @default.
- W2074032261 hasIssue "5" @default.
- W2074032261 hasLocation W20740322611 @default.
- W2074032261 hasOpenAccess W2074032261 @default.
- W2074032261 hasPrimaryLocation W20740322611 @default.
- W2074032261 hasRelatedWork W1987080890 @default.
- W2074032261 hasRelatedWork W2017325630 @default.
- W2074032261 hasRelatedWork W2287479431 @default.
- W2074032261 hasRelatedWork W2385055993 @default.
- W2074032261 hasRelatedWork W2392514423 @default.
- W2074032261 hasRelatedWork W2403564783 @default.
- W2074032261 hasRelatedWork W3031652481 @default.
- W2074032261 hasRelatedWork W4213220460 @default.
- W2074032261 hasRelatedWork W784175853 @default.
- W2074032261 hasRelatedWork W2055609503 @default.
- W2074032261 hasVolume "49" @default.
- W2074032261 isParatext "false" @default.
- W2074032261 isRetracted "false" @default.
- W2074032261 magId "2074032261" @default.
- W2074032261 workType "article" @default.